Abstract
Management of sedation and analgesia in the pediatric patient after cardiac surgery and cardiopulmonary bypass is of particular importance in the setting of decreased cardiac function and increased metabolic oxygen demands secondary to inflammatory responses. Important considerations include the relief of pain and anxiety, attenuation of the stress response, and maintaining mechanical ventilation synchrony. Opioid and benzodiazepine medications have historically been the mainstay sedative and analgesic agents in the intensive care unit, and they do indeed still have an important role. Still, other agents, such as dexmedetomidine, ketamine, propofol, and neuromuscular blockers, will help to provide a more balanced and tailored sedative and analgesic plan in order to maintain a level of non-agitation and hemodynamic stability in a wide variety of pediatric patients with specific needs. Additionally, many pediatric patients with congenital cardiac disease will require extracorporeal membrane oxygenation, which presents many pharmacokinetic implications that will significantly alter the pharmacodynamic effects of some of these drugs. Thus, the understanding of these alterations and the ability to adapt the patient’s sedative and analgesic plan to account for them is a necessity.
Steven E. Litchenstein is deceased at the time of publication of this chapter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Andropoulos DB, Stayer SA, Mossad EB, Miller-Hance WC. Anesthesia for congenital heart disease, 2nd ed. Hoboken, NJ: Wiley; 2015:603
Mertens LL, Schwartz SM. Sedation practices in pediatric cardiac ICUs after cardiopulmonary bypass. Pediatr Crit Care Med. 2016;17:369–370
Shi S, Zhao Z, Liu X, Shu Q, Tan L, Lin R, Shi Z, Fang X. Perioperative risk factors for prolonged mechanical ventilation following cardiac surgery in neonates and young infants. Chest. 2008;134:768–774
Laussen PC, Reid RW, Stene RA, Pare DS, Hickey PR, Jonas RA, Freed MD. Tracheal extubation of children in the operating room after atrial septal defect repair as part of a clinical practice guideline. Anesth Analg. 1996;82:988–993
Shew SB, Jaksic T. The metabolic needs of critically ill children and neonates. Semin Pediatr Surg. 1999;8:131–139
Anand KJS, Hansen DD, Hickey PR. Hormonal—metabolic stress responses in neonates undergoing cardiac surgery. Anesthesiology. 1990;73:661–670
Stoelting RK, Hillier S, Stoelting RK. Pharmacology & Physiology in Anesthetic Practice. Philadelphia: Lippincott Williams & Wilkins; 2006
Barash PG, Cullen BF, Stoelting RK, Cahalan MK, Stock MC, Ortega RA, Sharar SR, Holt NF. Opioids. In: Clinical Anesthesia. Philadelphia, PA: Wolters Kluwer; 2017:501–522
Pasternak GW. Opioid receptors. In: Handbook of Contemporary Neuropharmacology. Hoboken, NJ: Wiley; 2007, https://doi.org/10.1002/9780470101001.hcn044
Butterworth JF, Mackey DC, Wasnick JD. Analgesic agents. In: Morgan & Mikhailʼs Clinical Anesthesiology, 5th ed. New York: McGraw Hill; 2013:189–197
Mackenzie M, Zed PJ, Ensom MHH. Opioid pharmacokinetics-pharmacodynamics. Ann Pharmacother. 2016;50:209–218
Dervan LA, Yaghmai B, Watson RS, Wolf FM. The use of methadone to facilitate opioid weaning in pediatric critical care patients: a systematic review of the literature and meta-analysis. Pediatr Anesth. 2017;27:228–239
Gruber EM, Laussen PC, Casta A, et al. Stress response in infants undergoing cardiac surgery: a randomized study of fentanyl bolus, fentanyl infusion, and fentanyl-midazolam infusion. Anesth Analg. 2001;92:882–890
Motoyama EK, Davis PJ, Cladis FP. Pharmacology of pediatric anesthesia. In: Smiths anesthesia for infants and children. St. Louis, MO: Mosby; 2009:210–220
Faerber J, Zhong W, Dai D, Baehr A, Maxwell LG, Kraemer FW, Feudtner C. Comparative safety of morphine delivered via intravenous route vs. patient-controlled analgesia device for pediatric inpatients. J Pain Symptom Manage. 2017;53:842–850
Monitto CL, Greenberg RS, Kost-Byerly S, Wetzel RC, Yaster M. Safety and efficacy of parent/nurse controlled analgesia in patients less than 6 years of age. Anesthesiology. 1998;89:1324A
Motoyama EK, Davis PJ, Cladis FP. Pain management. In: Smith’s Anesthesia for Infants and Children. St. Louis, MO: Mosby; 2009
Silva PSCALD, Reis ME, Fonseca TSM, Fonseca MCM. Opioid and benzodiazepine withdrawal syndrome in PICU patients. J Addict Med. 2016;10:110–116
Bagley SM, Wachmann EM, Holland E, Brogly SM. Review of the assessment and management of neonatal abstinence syndrome. Addict Sci Clin Pract. 2014;9:1–10
Dahan A, Aarts L, Smith TW. Incidence, reversal, and prevention of opioid-induced respiratory depression. Anesthesiology. 2010;112:226–238
Moreland T, Brice J, Walker C, Parija A. Naloxone pharmacokinetics in the newborn. Br J Clin Pharmacol. 1980;9:609–612
Dowling J, Isbister GK, Kirkpatrick CMJ, Naidoo D, Graudins A. Population pharmacokinetics of intravenous, intramuscular, and intranasal naloxone in human volunteers. Ther Drug Monit. 2008;30(4):490–6.
Barrons RW, Woods JA. Low-dose naloxone for prophylaxis of postoperative nausea and vomiting: a systematic review and meta-analysis. Pharmacotherapy. 2017;37:546–554
Coté CJ. Sedation for the pediatric patient: a review. Pediatr Clin North Am. 1994;41:31–58
Coté CJ, Lerman J, Ward RM, Lugo RA, Goudsouzian N. Pharmacokinetics and pharmacology of drugs used in children. In: A Practice of Anesthesia for Infants and Children. Philadelphia, PA: Saunders; 2009: 89–146
Reves JG, Fragen RJ, Vinik HR, Greenblatt DJ. Midazolam. Anesthesiology. 1985;62:310–324
Dilorenzo AN, Schell RM. Intravenous Anesthetics. In: Morgan & Mikhail’s Clinical Anesthesiology, 5th ed. New York: McGraw-Hill; 2014:179–184
Sheridan RL, Keaney T, Stoddard F, Enfanto R, Kadillack P, Breault L. Short-term propofol infusion as an adjunct to extubation in burned children. J Burn Care Rehabil. 2003;24:356–360
Anand KJS, Willson DF, Berger J, et al. Tolerance and withdrawal from prolonged opioid use in critically ill children. Pediatrics. 2010; https://doi.org/10.1542/peds.2009-0489
Best KM, Boullata JI, Curley MAQ. Risk factors associated with iatrogenic opioid and benzodiazepine withdrawal in critically ill pediatric patients. Pediatr Crit Care Med. 2015;16:175–183
Shannon M, Albers G, Burkhart K, Liebelt E, Kelley M, Mccubbin MM, Hoffman J, Massarella J. Safety and efficacy of flumazenil in the reversal of benzodiazepine-induced conscious sedation. J Pediatr. 1997;131:582–586
Motoyama EK, Davis PJ, Cladis FP. Pharmacology of pediatric anesthesia. In: Smiths Anesthesia for Infants and Children. St. Louis, MO: Mosby; 2009:202
Tobias JD. Dexmedetomidine: Applications in pediatric critical care and pediatric anesthesiology. Pediatr Crit Care Med. 2007;8:115–131
Khan ZP, Ferguson CN, Jones RM. Alpha-2 and imidazoline receptor agonists: Their pharmacology and therapeutic role. Anaesthesia. 1999;54:146–165
Phan H, Nahata MC. Clinical uses of dexmedetomidine in pediatric patients. Pediatr Drugs. 2008;10:49–69
Mason KP, Lerman J. Dexmedetomidine in children. Anesth Analg. 2011;113:1129–1142
Dyck JB, Shafer SL. Dexmedetomidine pharmacokinetics and pharmacodynamics. Anesth Pharmacol Rev. 1993;1:238–245
Chrysostomou C, Filippo SD, Manrique A-M. Use of dexmedetomidine in children after cardiac and thoracic surgery. Pediatr Crit Care Med. 2006;7:194
Petroz GC, Sikich N, James M, et al. A phase I, 2-center study of the pharmacokinetics and pharmacodynamics of dexmedetomidine in children. Anesthesiology. 2006;105:1098–1110
Prielipp RC, Wall MH, Tobin JR, et al. Dexmedetomidine- induced sedation in volunteers decreases regional and global cerebral blood flow. Anesth Analg. 2002;95:1052–1059.
Karlsson BR, Forsman M, Roald OK, Heier MS, Steen PA. Effect of Dexmedetomidine, a selective and potent α2-agonist, on cerebral blood flow and oxygen consumption during halothane anesthesia in dogs. Anesth Analg. 1990; https://doi.org/10.1213/00000539-199008000-00003
Vartiainen J, MacDonald E, Urtri A, et al. Dexmedetomidine- induced ocular hypotension in rabbits with normal or elevated intracranial pressure. Invest Ophthalmol Vis Sci. 1992;33:2019–2023.
Doufas AG, Lin CM, Suleman MI, et al. Dexmedetomidine and meperidine actively reduce the shivering threshold in humans. Stroke. 2003;34:1218–1223
Hammer GB, Drover DR, Cao H. The effects of dexmedetomidine on cardiac electrophysiology in children. Anesth Analg. 2008;106:79–83
Belleville JP, Ward DS, Bloor BC, et al. Effects of intravenous dexmedetomidine in humans: sedation, ventilation, and metabolic rate. Anesthesiology. 1992;77:1125–1133.
Gertler R, Brown HC, Mitchell D, Silvius E. Dexmedetomidine: a novel sedative-analgesic agent. Proc (Bayl Univ Med Cent). 2001;14:13–21
Afonso J, Reis F. Dexmedetomidine: current role in anesthesia and intensive care. Braz J Anesthesiol. 2012;62:118–133
Kaur M, Singh P. Current role of dexmedetomidine in clinical anesthesia and intensive care. Anesth Essays Res. 2011;5:128
Lodge D, Mercier MS. Ketamine and phencyclidine: the good, the bad and the unexpected. Br J Pharmacol. 2015;172:4254–4276
Domino EF. Taming the ketamine tiger. Anesthesiology. 2010;113:678
Morray JP, Lynn AM, Stamm SJ, Herndon PS, Kawabori I, Stevenson JG. Hemodynamic effects of ketamine in children with congenital heart disease. Anesth Analg. 1984;63: 895–899.
Hickey PR, Hansen DD, Cramolini GM. Pulmonary and systemic hemodynamic responses to ketamine in infants with normal and elevated pulmonary vascular resistance. Anesthesiology. 1984;61:A438.
Raeder J. Ketamine, revival of a versatile intravenous anaesthetic. In: Advances in Modelling and Clinical Application of Intravenous Anaesthesia, Advances in Experimental Medicine and Biology. New York, NY/London: Kluwer Academic; 2003:269–277
Green SM, Denmark TK, Cline J, Roghair C, Allah SA, Rothrock SG. Ketamine sedation for pediatric critical care procedures. Pediatr Emerg Care. 2001;17:244–248
Vanlersberghe C, Camu F. Modern anesthetics. In: Handbook of Experimental Pharmacology. Berlin: Springer; 2008:227
Morgan D, Campbell G, Crankshaw D. Pharmacokinetics of propofol when given by intravenous infusion. Br J Clin Pharmacol. 1990;30:144–148
Khurmi N, Patel P, Kraus M, Trentman T. Pharmacologic considerations for pediatric sedation and anesthesia outside the operating room: a review for anesthesia and non-anesthesia providers. Pediatr Drugs. 2017;19:435–446
Marik P. Propofol: therapeutic indications and side-effects. Curr Pharm Des. 2004;10:3639–3649
Lee C. Structure, conformation, and action of neuromuscular blocking drugs†. Br J Anaesth. 2001;87:755–769
Barash PG, Cullen BF, Stoelting RK, Cahalan MK, Stock MC, Ortega RA, Sharar SR, Holt NF. Neuromuscular blocking agents. In: Clinical Anesthesia. Philadelphia, PA: Wolters Kluwer; 2017:522–563.
Naquib L, Miller RD, Erikson LI, Wiener-Kronish JP, Young WL. Pharmacology of muscle relaxants and their antagonists. In: Miller’s Anesthesia. Philadelphia, PA: Churchill Livingstone; 2010.
Hristovska AM, Duch P, Allingstrup M, Afshari A. Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults. Cochrane Database Syst Rev. 2017;8:CD012763.
Bridion (sugammadex) [prescribing information]. Whitehouse Station, NJ; Merck & Co, Inc; 2016.
Burda G, Trittenwein G. Issues of pharmacology in pediatric cardiac extracorporeal membrane oxygenation with special reference to analgesia and sedation. Artif Organs. 1999;23:1015–1019
Buck ML. Pharmacokinetic changes during extracorporeal membrane oxygenation. Clin Pharmacokinet. 2003;42:403–417
Harthan A, Buckley K, Heger M, Fortuna R, Mays K. Medication adsorption into contemporary extracorporeal membrane oxygenator circuits. J Pediatr Pharmacol Ther. 2014;19:288–295
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Roney, G., Jooste, E.H., Callahan, P.M., Litchenstein, S.E., Davis, P.J., Adams, P.S. (2020). Sedation and Analgesia. In: Munoz, R., Morell, V., da Cruz, E., Vetterly, C., da Silva, J. (eds) Critical Care of Children with Heart Disease . Springer, Cham. https://doi.org/10.1007/978-3-030-21870-6_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-21870-6_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-21869-0
Online ISBN: 978-3-030-21870-6
eBook Packages: MedicineMedicine (R0)